Literature DB >> 6514012

Stereoselective inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by 4-dimethylamino-2,alpha-dimethylphenethylamine (FLA 336).

C J Fowler, M Eriksson, G Thorell, O Magnusson.   

Abstract

The in vitro inhibition by amiflamine [FLA 336(+)] and related compounds of the activity of rat monoamine oxidase (MAO) -A and -B, rat semicarbazide sensitive amine oxidase (SSAO) and human platelet poor plasma benzylamine oxidase was studied. Amiflamine was an MAO-A selective inhibitor, but also inhibits SSAO with both a reversible (competitive, Ki = 200 mumol/l) and a small time-dependent component which was irreversible in nature. The optical isomer FLA 336(-) was ten times less potent towards MAO-A. However, this compound was much more potent an inhibitor of SSAO (competitive, Ki = 4.6 mumol/l). The amiflamine metabolites FLA 788(+) and FLA 668(+) inhibited SSAO, but only at concentrations considerably higher than required for MAO-A inhibition. Ex vivo experiments indicated that there was no significant irreversible inhibition of rat heart and lung SSAO after both single and repeated administration of amiflamine at doses up to 20 times higher than required for inhibition of MAO-A within central serotoninergic neurones.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6514012     DOI: 10.1007/bf00506237

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  15 in total

Review 1.  Series on pharmacology in practice: 1. Drugs that alter mood. I. Tricyclic agents and monoamine oxidase inhibitors.

Authors:  A H Rosenbaum; T Maruta; E Richelson
Journal:  Mayo Clin Proc       Date:  1979-05       Impact factor: 7.616

2.  On the stereospecificity of monoamine oxidase.

Authors:  C H Williams
Journal:  J Pharm Pharmacol       Date:  1982-06       Impact factor: 3.765

3.  Monoamine oxidase inhibitors in resistant depression.

Authors:  C M Pare
Journal:  Int Pharmacopsychiatry       Date:  1979

Review 4.  Selective inhibitors of monoamine oxidase A and B: biochemical, pharmacological, and clinical properties.

Authors:  C J Fowler; S B Ross
Journal:  Med Res Rev       Date:  1984 Jul-Sep       Impact factor: 12.944

Review 5.  Monoamine oxidase activity and localisation in the brain and the activity in relation to psychiatric disorders.

Authors:  L Oreland; Y Arai; A Stenström; C J Fowler
Journal:  Mod Probl Pharmacopsychiatry       Date:  1983

6.  A comparison of cardiac and vascular clorgyline-resistant amine oxidase and monoamine oxidase. Inhibition by amphetamine, mexiletine and other drugs.

Authors:  D E Clarke; G A Lyles; B A Callingham
Journal:  Biochem Pharmacol       Date:  1982-01-01       Impact factor: 5.858

7.  Monoamine oxidase activities in brown adipose tissue of the rat: some properties and subcellular distribution.

Authors:  M A Barrand; B A Callingham
Journal:  Biochem Pharmacol       Date:  1982-06-15       Impact factor: 5.858

8.  Monoamine oxidase inhibitors. A review of antidepressant effectiveness.

Authors:  F Quitkin; A Rifkin; D F Klein
Journal:  Arch Gen Psychiatry       Date:  1979-07

9.  Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.

Authors:  A L Ask; I Fagervall; S B Ross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

10.  (+)-4-Dimethylamino-2,alpha-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain.

Authors:  A L Ask; K Högberg; L Schmidt; H Kiessling; S B Ross
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

View more
  1 in total

1.  Inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by mexiletine and related compounds.

Authors:  M Eriksson; C J Fowler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.